receives

BostonGene Receives Frost & Sullivan’s 2026 Global Company of the Year for Advancing in AI-Driven Multimodal Oncology Platforms

Recognition highlights BostonGene's leadership in improving drug development decisions,reducing risk and accelerating patient impactSAN ANTONIO, May 5, 2026 /PRNewswire/ -- Frost &…

1 month ago

Centrical Receives Frost & Sullivan’s 2026 Global Transformational Innovation Leadership Recognition for Excellence in Performance Intelligence

Recognized for advancing performance intelligence through transformational innovation that enhances frontline productivity, engagement, and business outcomes.SAN ANTONIO, April 28, 2026…

2 months ago

BIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-K Filing

HOLMDEL, N.J., April 22, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management…

2 months ago

Brigade Electronics Receives Frost & Sullivan’s 2026 European Market Leadership Recognition in the Commercial Vehicle Safety Systems Industry for Excellence in Fleet-Wide Safety Technology Standardization

Brigade Electronics is a leading hardware-centric supplier for leveraging safety regulations and fleet-wide technology to deliver reliable, user-friendly solutions.SAN ANTONIO,…

2 months ago

Frost & Sullivan: Innovapptive Receives the 2026 Global Augmented Connected Worker, End-to-End Platforms Company of the Year Recognition for Excellence in AI-Powered Connected Worker Execution

Recognized for advancing platform development and enabling unified execution layer capabilities that transform frontline workflows and operational efficiency.SAN ANTONIO, April…

2 months ago

Lumen Receives Frost & Sullivan’s 2026 North American Broadcast Video Managed Services Recognition for Excellence in Purpose-Built Broadcast Reliability and Operational Efficiency

Recognized for delivering purpose-built broadcast services that enhance operational efficiency, reliability, and seamless end-to-end workflow integration.SAN ANTONIO, April 20, 2026…

2 months ago

MISTRAS Group Receives Frost & Sullivan’s 2026 Global NDT Field Inspection Services Company of the Year Recognition for Excellence in Integrated Asset Integrity and Digital Execution

MISTRAS Group delivers customer-centric asset integrity solutions that drive operational efficiency and performance improvement across global industries.SAN ANTONIO, April 14,…

2 months ago

Nxera Pharmas QUVIVIQ (daridorexant) 25mg and 50mg Receives Approval in Taiwan for the Treatment of Insomnia

Nxera’s partner Holling Bio-Pharma Corp. will commercialize QUVIVIQ® in Taiwan, a market with approximately 4–5 million patients, with launch planned during 2026QUVIVIQ®…

2 months ago

Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy – CORRECTION

April 10, 2026 16:09 ET  | Source: Mesoblast Limited Working with Parent Project Muscular Dystrophy and the Duchenne Registry on…

2 months ago

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

April 10, 2026 17:02 ET  | Source: Replimune, Inc. WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc.…

2 months ago